Mizuho downgrades Hologic stock to Neutral following acquisition deal
NegativeFinancial Markets

Mizuho has downgraded Hologic's stock to a neutral rating following the company's recent acquisition deal. This move reflects concerns about the potential impacts of the acquisition on Hologic's future performance. Investors should pay attention to how this change might affect the stock's trajectory and the company's strategic direction.
— Curated by the World Pulse Now AI Editorial System









